RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Mannitol

Reduction of intracranial pressure, Treatment of cerebral edema, Reduction of intraocular pressure

Indications

  • Reduction of intracranial pressure
  • Treatment of cerebral edema
  • Reduction of intraocular pressure

Adult dosing

  • intracranial pressure: dose: 0.25; unit: g/kg; route: IV; interval: over at least 30 minutes; repeat no more often than every 6 to 8 hours; weightBased: true; labelExcerpt: Usually a maximum reduction in intracranial pressure can be achieved with a dose of 0.25 g/kg
  • intraocular pressure: dose: 1.5; unit: g/kg; route: IV; interval: single dose (1.5 to 2 g/kg) over at least 30 minutes; weightBased: true; labelExcerpt: The recommended dosage is 1.5 to 2 g/kg as a single dose administered as an intravenous infusion over at least 30 minutes

Pediatric dosing

  • Consult pharmacy/current label

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Consult pharmacy/current label

Contraindications

  • Hypersensitivity to mannitol
  • Anuria
  • Severe hypovolemia
  • Pre-existing pulmonary edema
  • Active intracranial bleeding

Clinical pearls

  • Use a filter for infusion to prevent crystals.
  • Do not administer with blood products due to potential pseudoagglutination.
  • Monitor fluid, electrolytes, and renal function closely during and after infusion.
  • Warm vials at 80°C to dissolve crystals prior to use.

Source and review

  • DailyMed label (mannitol), Set ID e2444db1-9dfe-451f-a33c-9b00786464d2, effective 2026-11-02. Last reviewed: 2026-11-11